Methylation-regulated tumor suppressor gene PDE7B promotes HCC invasion and metastasis through the PI3K/AKT signaling pathway

• Published in: BMC cancer 2024-05, Vol.24 (1), p.624-19, Article 624
• Main Authors: Du, Yuanxiao, Xu, Yuqiu, Guo, Xuefeng, Tan, Chao, Zhu, Xiaonian, Liu, Guoyu, Lyu, Xiao, Bei, Chunhua
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Analysis; Bisulfite; Canada; Cancer; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - pathology; Care and treatment; Cell Line, Tumor; Cell Movement - genetics; Cell Proliferation - genetics; China; Cyclic Nucleotide Phosphodiesterases, Type 7 - genetics; Cyclic Nucleotide Phosphodiesterases, Type 7 - metabolism; Development and progression; Diagnosis; DNA; DNA Methylation; DNA methyltransferase; Epigenetics; Female; Gene Expression Regulation, Neoplastic; Genes; Genes, Tumor Suppressor; Genetic aspects; Genetic research; Genetic transcription; Genomes; Genomics; Health aspects; Hepatocellular carcinoma; Hepatoma; Humans; Kinases; Liver cancer; Liver Neoplasms - genetics; Liver Neoplasms - pathology; Male; Mass spectroscopy; Metastases; Metastasis; Methylation; Mortality; Neoplasm Invasiveness - genetics; Neoplasm Metastasis; PDE7B; Phosphatidylinositol 3-Kinases - genetics; Phosphatidylinositol 3-Kinases - metabolism; PI3K/AKT; Proto-Oncogene Proteins c-akt - metabolism; Rap1 protein; Ribosomes; RNA; RNA sequencing; Signal transduction; Signal Transduction - genetics; Sulfites; Therapeutic targets; Transferases; Tumor suppressor genes; Tumors
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-024-12364-w

Hepatocellular carcinoma (HCC) has a high mortality rate, and the mechanisms underlying tumor development and progression remain unclear. However, inactivated tumor suppressor genes might play key roles. DNA methylation is a critical regulatory mechanism for inactivating tumor suppressor genes in HCC. Therefore, this study investigated methylation-related tumor suppressors in HCC to identify potential biomarkers and therapeutic targets. We assessed genome-wide DNA methylation in HCC using whole genome bisulfite sequencing (WGBS) and RNA sequencing, respectively, and identified the differential expression of methylation-related genes, and finally screened phosphodiesterase 7B (PDE7B) for the study. The correlation between PDE7B expression and clinical features was then assessed. We then analyzed the changes of PDE7B expression in HCC cells before and after DNA methyltransferase inhibitor treatment by MassArray nucleic acid mass spectrometry. Furthermore, HCC cell lines overexpressing PDE7B were constructed to investigate its effect on HCC cell function. Finally, GO and KEGG were applied for the enrichment analysis of PDE7B-related pathways, and their effects on the expression of pathway proteins and EMT-related factors in HCC cells were preliminarily explored. HCC exhibited a genome-wide hypomethylation pattern. We screened 713 hypomethylated and 362 hypermethylated mCG regions in HCC and adjacent normal tissues. GO analysis showed that the main molecular functions of hypermethylation and hypomethylation were "DNA-binding transcriptional activator activity" and "structural component of ribosomes", respectively, whereas KEGG analysis showed that they were enriched in "bile secretion" and "Ras-associated protein-1 (Rap1) signaling pathway", respectively. PDE7B expression was significantly down-regulated in HCC tissues, and this low expression was negatively correlated with recurrence and prognosis of HCC. In addition, DNA methylation regulates PDE7B expression in HCC. On the contrary, overexpression of PDE7B inhibited tumor proliferation and metastasis in vitro. In addition, PDE7B-related genes were mainly enriched in the PI3K/ATK signaling pathway, and PDE7B overexpression inhibited the progression of PI3K/ATK signaling pathway-related proteins and EMT. PDE7B expression in HCC may be regulated by promoter methylation. PDE7B can regulate the EMT process in HCC cells through the PI3K/AKT pathway, which in turn affects HCC metastasis and invasion.